Success with ipilimumab in prostate cancer patients
Mayo researchers: Dramatic outcomes in prostate cancer study – Success with ipilimumab or MDX-010 in prostate cancer patients – Two Mayo Clinic patients whose prostate cancer had been considered inoperable are now cancer free thanks in part to an experimental drug therapy that was used in combination with standardized hormone treatment and radiation therapy.